On May 25, 2011, representatives of Advocure NF2, Inc. visited Dr. Marco Giovannini at the House Research Institute’s (HRI) Center for Neural Tumor Research (CNTR).A plaque of Appreciation for HRI’s continuing NF2 research was presented to Dr. Giovannini and his laboratory colleagues. The following is a summary of the conversation between Dr. Marco Giovannini and… Continue Reading →
News & Announcements
Dec 30, 2010: ‘NF2 News’ winter 2010 newsletter by the NFA, in the UK. – Interesting opening article on the NFA’s new 5 year plan. Also, a very interesting article on Avastin™ for NF2, page 7. Dec 1, 2010: CTF announces a Phase 2 of the DDI ‘NF Preclinical Consortium’ (NFPC). Funding (at $1/4M each… Continue Reading →
The 6th annual Halloween Bash to benefit Children‘s Hospital Oakland and to find a cure for Neurofibromatosis type 2 took place on Friday, October 22nd in Walnut Creek, California. Roland and Nicole Thoms have been throwing this Halloween party since 2003, a year after their daughter,Camille (then 7 years old) was taken to the hospital… Continue Reading →
Advocure NF2 Inc wrote to and asked Dr. Naba Bora of the Congressional Directed Research Programs (CDMRP NFRP) for clarification on CDMRP’s grant funding mechanism, as well as to explain its present NF Consortium centers lack of ̳NF2 expertise.
On August 23, 2010, Advocure NF2 was invited to participate in a conference call with both Bruce R. Korf, MD, PhD (Principal Investigator of the NF Consortium) and Dr. Roger Packer (Chair of the Consortium), in order to clarify the NF Consortium’s timeline on NF2’s inclusion for trials.